Exchange: NASDAQ·Updated 07:50 PM EDT

BRVE Braveheart Bio Inc.

$20.02
$0.93
(4.87%)
Today
Closed $20.02
$0.40
(2.00%)
After Hours
EarningsNov 12
Mkt Cap$1.8B
Vol255,238.00

About BRVE

Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor. The company was founded on May 13,2024 and is headquartered in San Francisco, CA.
38

Bearish Sentiment

How do you feel about BRVE?

Advertisement|Remove ads.